Study #2018-0344
Pilot trial of LET optimized IMPT for pediatric patients with ependymoma
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase I trial studies the side effects of linear energy transfer (LET) optimized image modulated proton therapy (IMPT) in treating pediatric patients with ependymoma. Radiation therapy such as LET optimized IMPT, uses proton beams to kill tumor cells and shrink tumors without damaging surrounding normal tissues.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Anaplastic Ependymoma;Ependymoma
Study phase:
Phase I
Physician name:
David Grosshans
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.